Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,197
archived clinical trials in
Atrial Fibrillation

Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
HealthEast Medical Research Institute
mi
from
Saint Paul, MN
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
HealthEast Medical Research Institute
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Jackson Heart Clinic
mi
from
Jackson, MS
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Jackson Heart Clinic
mi
from
Jackson, MS
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Associates of the Delaware Valley
mi
from
Elmer, NJ
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Associates of the Delaware Valley
mi
from
Elmer, NJ
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Lourdes Cardiology Services
mi
from
Voorhees, NJ
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Lourdes Cardiology Services
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Duke Cardiology of Lumberton
mi
from
Lumberton, NC
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Duke Cardiology of Lumberton
mi
from
Lumberton, NC
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Doylestown Health Cardiology
mi
from
Doylestown, PA
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Doylestown Health Cardiology
mi
from
Doylestown, PA
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Columbia Heart Clinic
mi
from
Columbia, SC
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Columbia Heart Clinic
mi
from
Columbia, SC
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
North Texas Research Associates
mi
from
Allen, TX
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
North Texas Research Associates
mi
from
Allen, TX
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Providence Health Center
mi
from
Waco, TX
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Providence Health Center
mi
from
Waco, TX
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Riverside Cardiology Specialists
mi
from
Newport News, VA
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Riverside Cardiology Specialists
mi
from
Newport News, VA
Click here to add this to my saved trials
ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization
Panoramic ECGi to Guide Ablation of Non-Paroxysmal AF: Effect of Ibutilide on AF Source Location and Organization
Status: Enrolling
Updated:  12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization
Panoramic ECGi to Guide Ablation of Non-Paroxysmal AF: Effect of Ibutilide on AF Source Location and Organization
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients
Comparative Effectiveness of Rivaroxaban and Warfarin for Stroke Prevention in Multi-morbid Patients With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Truven Health MarketScan Commercial Claims and Medicare Supplemental Databases
mi
from
Multiple Locations, WA
Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients
Comparative Effectiveness of Rivaroxaban and Warfarin for Stroke Prevention in Multi-morbid Patients With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Truven Health MarketScan Commercial Claims and Medicare Supplemental Databases
mi
from
Multiple Locations, WA
Click here to add this to my saved trials
A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium Enhancement
A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium
Status: Enrolling
Updated:  12/31/1969
Saint Luke's Health System
mi
from
Kansas City, MO
A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium Enhancement
A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium
Status: Enrolling
Updated: 12/31/1969
Saint Luke's Health System
mi
from
Kansas City, MO
Click here to add this to my saved trials
Atrial Fibrillation Screening and Education Study
Evaluation of a Community-Placed Atrial Fibrillation Screening and Education Program
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Atrial Fibrillation Screening and Education Study
Evaluation of a Community-Placed Atrial Fibrillation Screening and Education Program
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation
Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation: A Randomized Trial
Status: Enrolling
Updated:  12/31/1969
Michigan Medicine
mi
from
Ann Arbor, MI
Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation
Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation: A Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Michigan Medicine
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Arkansas Heart Hospital
mi
from
Little Rock, AR
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Arkansas Heart Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Scripps Health
mi
from
La Jolla, CA
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Scripps Health
mi
from
La Jolla, CA
Click here to add this to my saved trials
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
South Denver Cardiology Associates
mi
from
Littleton, CO
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
South Denver Cardiology Associates
mi
from
Littleton, CO
Click here to add this to my saved trials
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Florida Hospital
mi
from
Orlando, FL
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
New York University Hospital
mi
from
New York, NY
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
New York University Hospital
mi
from
New York, NY
Click here to add this to my saved trials
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Texas Cardiac Arrhythmia
mi
from
Austin, TX
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Texas Cardiac Arrhythmia
mi
from
Austin, TX
Click here to add this to my saved trials
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Sequoia Hospital
mi
from
Redwood City, CA
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Sequoia Hospital
mi
from
Redwood City, CA
Click here to add this to my saved trials
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Central Baptist Hospital
mi
from
Lexington, KY
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Central Baptist Hospital
mi
from
Lexington, KY
Click here to add this to my saved trials
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Ashford Hospital
mi
from
Adelaide,
TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Ashford Hospital
mi
from
Adelaide,
Click here to add this to my saved trials
Post-Market Surveillance With a Novel mHealth Platform
Post-Market Surveillance With a Novel mHealth Platform
Status: Enrolling
Updated:  12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Post-Market Surveillance With a Novel mHealth Platform
Post-Market Surveillance With a Novel mHealth Platform
Status: Enrolling
Updated: 12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Post-Market Surveillance With a Novel mHealth Platform
Post-Market Surveillance With a Novel mHealth Platform
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Post-Market Surveillance With a Novel mHealth Platform
Post-Market Surveillance With a Novel mHealth Platform
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
SMART Program for Paroxysmal Atrial Fibrillation
A SMART Approach to Reducing Atrial Fibrillation Symptoms
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
SMART Program for Paroxysmal Atrial Fibrillation
A SMART Approach to Reducing Atrial Fibrillation Symptoms
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Characterization and Prediction of Atrial Fibrillation-caused Adverse Events After Hospital Discharge for Cardiac Surgery
Massachusetts-wide Study of the Incidence of ATrial Fibrillation and Stroke Occurring After Discharge From Cardiac Surgery (MATRICeS)
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Characterization and Prediction of Atrial Fibrillation-caused Adverse Events After Hospital Discharge for Cardiac Surgery
Massachusetts-wide Study of the Incidence of ATrial Fibrillation and Stroke Occurring After Discharge From Cardiac Surgery (MATRICeS)
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)
Investigating the Association of Type of Anticoagulation Treatment for Non-valvular Atrial Fibrillation and Risk of Bleeding in England
Status: Enrolling
Updated:  12/31/1969
Local Institution
mi
from
Bethesda, MD
Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)
Investigating the Association of Type of Anticoagulation Treatment for Non-valvular Atrial Fibrillation and Risk of Bleeding in England
Status: Enrolling
Updated: 12/31/1969
Local Institution
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure
Real-World Comparative Effectiveness Research Among Elderly Non-valvular Atrial Fibrillation (NVAF) Patients With Heart Failure (HF) Using Oral Anticoagulants
Status: Enrolling
Updated:  12/31/1969
Local Institution
mi
from
Ann Arbor, MI
Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure
Real-World Comparative Effectiveness Research Among Elderly Non-valvular Atrial Fibrillation (NVAF) Patients With Heart Failure (HF) Using Oral Anticoagulants
Status: Enrolling
Updated: 12/31/1969
Local Institution
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Metformin as an Upstream Therapy in Atrial Fibrillation
Metformin as an Upstream Therapy in Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Guthrie Clinic, Ltd.
mi
from
Sayre, PA
Metformin as an Upstream Therapy in Atrial Fibrillation
Metformin as an Upstream Therapy in Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Guthrie Clinic, Ltd.
mi
from
Sayre, PA
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Yuma, AZ
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Yuma, AZ
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fayetteville, AR
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fort Smith, AR
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bakersfield, CA
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Berkeley, CA
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Berkeley, CA
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Aurora, CO
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Stamford, CT
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Stamford, CT
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Clearwater, FL
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Daytona Beach, FL
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Ormond Beach, FL
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials